• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖增加 2 型糖尿病青年患者肝纤维化的风险:需要进行筛查。

Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen.

机构信息

Division of Endocrinology, Diabetes and Metabolism, University of Florida College of Medicine, Gainesville, Florida, USA.

Advanced Magnetic Resonance Imaging and Spectroscopy Facility, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.

出版信息

Obesity (Silver Spring). 2024 Oct;32(10):1967-1974. doi: 10.1002/oby.24130.

DOI:10.1002/oby.24130
PMID:39315409
Abstract

OBJECTIVE

The objective of this study was to determine the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in young compared with older adults.

METHODS

Individuals (n = 1420) with (63%) and without type 2 diabetes mellitus (T2D; 37%) who attended internal medicine clinics and did not have a known history of MASLD underwent laboratory evaluation and transient elastography to assess for hepatic steatosis and fibrosis. Magnetic resonance elastography and liver biopsy were recommended when indicated.

RESULTS

A total of 243 participants were ages <45 years, and 1177 were ages ≥45 years. Obesity, T2D, and metabolic syndrome were highly prevalent in young adults. Frequencies of steatosis and fibrosis were high in young adults (50.2% and 7.5% vs. older adults 52.7% and 9.9%, respectively) and were significantly higher in those with both obesity and T2D (71.1% and 15.7%, respectively; p < 0.01). In young adults, T2D and obesity were the strongest risk factors for hepatic fibrosis (odds ratios 4.33 [95% CI: 1.37-13.68] and 1.16 [95% CI: 1.07-1.25], respectively; p < 0.05).

CONCLUSIONS

There is a high prevalence of clinically significant hepatic fibrosis in young adults with cardiometabolic risk factors. Up to one in seven young adults with obesity and T2D had clinically significant hepatic fibrosis on elastography. This highlights the need to screen young adults with cardiometabolic risk factors for MASLD for early detection and intervention.

摘要

目的

本研究旨在确定与老年人相比,年轻人代谢功能障碍相关脂肪性肝病(MASLD)的患病率。

方法

参加内科诊所就诊且无 MASLD 已知病史的个体(n=1420)进行实验室评估和瞬时弹性成像,以评估肝脂肪变性和纤维化。建议在有指征时进行磁共振弹性成像和肝活检。

结果

共有 243 名参与者年龄<45 岁,1177 名参与者年龄≥45 岁。肥胖、2 型糖尿病(T2D)和代谢综合征在年轻人中非常普遍。年轻人的脂肪变性和纤维化频率较高(分别为 50.2%和 7.5%,而老年人分别为 52.7%和 9.9%),并且在肥胖和 T2D 并存的患者中明显更高(分别为 71.1%和 15.7%;p<0.01)。在年轻人中,T2D 和肥胖是肝纤维化的最强危险因素(比值比 4.33[95%CI:1.37-13.68]和 1.16[95%CI:1.07-1.25];p<0.05)。

结论

有代谢风险因素的年轻人中存在较高比例的临床显著肝纤维化。多达七分之一的肥胖和 T2D 年轻人在弹性成像上存在临床显著的肝纤维化。这突出表明需要对有代谢风险因素的年轻人进行 MASLD 筛查,以进行早期发现和干预。

相似文献

1
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen.肥胖增加 2 型糖尿病青年患者肝纤维化的风险:需要进行筛查。
Obesity (Silver Spring). 2024 Oct;32(10):1967-1974. doi: 10.1002/oby.24130.
2
Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.累积甲氨蝶呤剂量与有中重度银屑病病史患者的肝纤维化无关。
Br J Dermatol. 2024 Jul 16;191(2):275-283. doi: 10.1093/bjd/ljae069.
3
Assessing Fibrosis and Steatosis utilizing Transient Elastography (Fibroscan) in Metabolic-dysfunction Associated Steatotic Liver Disease: An Experience from UBTH, Benin City, Nigeria.在代谢功能障碍相关脂肪性肝病中利用瞬时弹性成像(Fibroscan)评估肝纤维化和脂肪变性:来自尼日利亚贝宁城UBTH的经验
West Afr J Med. 2025 Feb 28;42(2):127-136.
4
Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.评估瞬时弹性成像技术在诊断 MAFLD 中的应用,以及袖状胃切除术对中国人 MAFLD 的早期影响。
Int J Surg. 2024 Apr 1;110(4):2044-2054. doi: 10.1097/JS9.0000000000001078.
5
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
6
Transient elastography and controlled attenuation parameter to evaluate hepatic steatosis and liver stiffness in postpartum patients.瞬时弹性成像和受控衰减参数评估产后患者的肝脂肪变性和肝硬度。
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2190838. doi: 10.1080/14767058.2023.2190838.
7
Comparison of the magnetic resonance elastography and FIB-4 (MEFIB) Index and vibration-controlled transient elastography for significant metabolic dysfunction-associated steatotic liver disease fibrosis.磁共振弹性成像与FIB-4(MEFIB)指数及振动控制瞬时弹性成像在显著代谢功能障碍相关脂肪性肝病肝纤维化中的比较
Can Liver J. 2024 Dec 19;7(4):419-426. doi: 10.3138/canlivj-2024-0007. eCollection 2024 Dec.
8
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic Perspective.从“燃尽”到“正在燃尽”:从动态角度捕捉晚期代谢功能障碍相关脂肪性肝病患者的肝脏脂肪减少情况。
Gastroenterology. 2025 Mar 18. doi: 10.1053/j.gastro.2025.02.034.
9
Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study.1型糖尿病成人患者在接受振动控制瞬时弹性成像检查时,连续血糖监测指标与代谢功能障碍相关脂肪性肝病之间的关联:一项多中心横断面研究
Diabetes Metab. 2025 Sep;51(5):101684. doi: 10.1016/j.diabet.2025.101684. Epub 2025 Jul 5.
10
MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in India.MISHTI研究评估印度2型糖尿病患者的肝纤维化情况。
Sci Rep. 2025 Jul 9;15(1):24772. doi: 10.1038/s41598-025-10871-9.

引用本文的文献

1
Early-Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials.早发性肥胖与替尔泊肽治疗:SURMOUNT临床试验的事后分析
Obesity (Silver Spring). 2025 Sep;33(9):1668-1679. doi: 10.1002/oby.24348. Epub 2025 Jul 27.
2
Explainable machine learning-driven models for predicting Parkinson's disease and its prognosis: obesity patterns associations and models development using NHANES 1999-2018 data.用于预测帕金森病及其预后的可解释机器学习驱动模型:肥胖模式关联以及使用1999 - 2018年美国国家健康与营养检查调查(NHANES)数据进行模型开发
Lipids Health Dis. 2025 Jul 17;24(1):241. doi: 10.1186/s12944-025-02664-w.
3

本文引用的文献

1
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care.胰岛素抵抗在2型糖尿病患者非酒精性脂肪性肝病发生发展中的作用:从实验室到患者护理
Diabetes Spectr. 2024 Winter;37(1):20-28. doi: 10.2337/dsi23-0013. Epub 2024 Feb 15.
2
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.4. 合并症的综合医学评估:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S52-S76. doi: 10.2337/dc24-S004.
3
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes.
无肥胖和糖尿病人群中心血管代谢标志物与肝脂肪变性及肝纤维化的关联
Sci Rep. 2025 May 5;15(1):15695. doi: 10.1038/s41598-025-01003-4.
4
Fat, fibrosis, and the future: navigating the maze of MASLD/MASH.脂肪、纤维化与未来:探索MAFLD/MASH的迷宫
J Clin Invest. 2025 Apr 1;135(7):e186418. doi: 10.1172/JCI186418.
美国 2 型糖尿病、糖尿病前期、代谢不健康和代谢健康个体中非酒精性脂肪性肝病(NAFLD)和相关死亡率。
Metabolism. 2023 Sep;146:155642. doi: 10.1016/j.metabol.2023.155642. Epub 2023 Jun 26.
4
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis.代谢综合征及其与非酒精性脂肪性肝炎的关系。
Clin Liver Dis. 2023 May;27(2):187-210. doi: 10.1016/j.cld.2023.01.002. Epub 2023 Feb 26.
5
Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.美国 2009 年至 2020 年 20 至 44 岁成年人心血管危险因素流行率、治疗和控制情况。
JAMA. 2023 Mar 21;329(11):899-909. doi: 10.1001/jama.2023.2307.
6
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
7
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.一项关于 2 型糖尿病患者非酒精性脂肪性肝病、肝纤维化、肝硬化和肝细胞癌患病率的前瞻性研究。
J Hepatol. 2023 Mar;78(3):471-478. doi: 10.1016/j.jhep.2022.11.010. Epub 2022 Nov 19.
8
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.脂肪组织胰岛素抵抗可预测2型糖尿病合并非酒精性脂肪性肝病患者肝纤维化的严重程度。
J Clin Endocrinol Metab. 2023 Apr 13;108(5):1192-1201. doi: 10.1210/clinem/dgac660.
9
The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.美国青少年和年轻成年人中酒精性和非酒精性脂肪性肝病的流行率:NHANES 数据库分析。
BMC Gastroenterol. 2022 Jul 30;22(1):366. doi: 10.1186/s12876-022-02430-7.
10
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.即使在体型偏瘦的个体中,脂肪组织功能障碍和内脏脂肪也与肝脏胰岛素抵抗及非酒精性脂肪性肝炎的严重程度相关。
Liver Int. 2022 Nov;42(11):2418-2427. doi: 10.1111/liv.15377. Epub 2022 Aug 18.